Craig Johnson's practice focuses on mergers and acquisitions, corporate finance, and general securities and corporate matters. Craig has represented acquirers and targets on a variety of M&A transactions, including public and private company mergers, asset acquisitions, and divestitures and strategic transactions. In the corporate finance area, he has represented issuers and investment banks in public and private equity offerings. His experience spans a broad range of industries, including technology, hospitality and gaming, semiconductor, medical device, and pharmaceuticals, and includes work for such companies as Allergan, The Carlyle Group, Credit Suisse, FileNet, Harrah's Entertainment, ICOS Corporation, Jazz Semiconductor, Piper Jaffray, and Watson Pharmaceuticals.
